Response to 'Interpreting tafamidis effectiveness within the evolving phenotype of contemporary ATTRwt cardiomyopathy'

Scritto il 02/03/2026
da Aldostefano Porcari

No abstract

Eur J Heart Fail. 2026 Jan 21:xuag021. doi: 10.1093/ejhf/xuag021. Online ahead of print.

NO ABSTRACT

PMID:41771139 | DOI:10.1093/ejhf/xuag021